Physician profile
Jason Kloby
NPI 1659465524
$1,441.89
in general payments reported to CMS, 2019-2025
14 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.33 · 2022: $342 · 2023: $241 · 2024: $311 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,059.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $378.40 | 2021-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $297.03 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $151.37 | 2023-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $131.96 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $131.43 | 2022-2025 | |
| Glaxosmithkline, LLC. | $105.88 | 2021-2024 | Shingrix, Arexvy |
| Lilly USA, LLC | $82.59 | 2022-2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $42.10 | 2025 | |
| Abbott Laboratories | $36.01 | 2023-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.05 | 2022 | |
| Dexcom, INC. | $19.00 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.01 | 2025 | Jardiance |
| Qol Medical, LLC | $14.35 | 2022 | |
| Braintree Laboratories, INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Kloby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.